The transcription regulator ID3 maintains tumor-specific memory CD8+ T cells in draining lymph nodes during tumorigenesis
During tumorigenesis, the recently identified tumor-specific memory T cells in draining lymph nodes (TdLN-T<sub>TSM</sub> cells) play a pivotal role in tumor repression that gives rise to progenitor exhausted T (T<sub>PEX</sub>) cells and further replenishes tumor-specific CD8<sup>+</sup> T cells residing in the tumor microenvironment (TME). However, how T<sub>TSM</sub> cells are maintained in TdLN is largely unknown. Here, we show that the transcription regulator ID3 (inhibitor of DNA binding 3) is highly expressed by T<sub>TSM</sub> cells compared with other CD8<sup>+</sup> T cell subsets. The deficiency of ID3 significantly interrupts the maintenance of T<sub>TSM</sub> and T<sub>PEX</sub> cells, resulting in decreased tumor-infiltrating CD8<sup>+</sup> T cells and impaired tumor control. Consistent with this, overexpression of ID3 in CD8<sup>+</sup> T cells increases the T<sub>TSM</sub> cell population and enhances the anti-tumor immune response.
Authors
- Zhengliang Yue
- Lifan Xu
- Mengqu Ran
- Xingxing Su
- Luming Xu (ORCID: https://orcid.org/0000-0002-3746-1332)
- Shun� Lei
- Yezi Chen
- Lilin Ye (ORCID: https://orcid.org/0000-0003-0778-3311)
- Wen Liu (ORCID: https://orcid.org/0000-0003-3434-4162)
- Qiao Liu (ORCID: https://orcid.org/0000-0002-9781-3360)
- Yan Zhang (ORCID: https://orcid.org/0000-0003-0998-5072)
- Yuzhu Wang (ORCID: https://orcid.org/0000-0002-0230-5452)
- Lisha Wang
- Jianjun Hu (ORCID: https://orcid.org/0000-0001-5393-880X)
- Zhanpeng Ou (ORCID: https://orcid.org/0000-0003-3710-7058)
- Qizhao Huang
- Ling Ran (ORCID: https://orcid.org/0009-0007-8097-0857)
- Shuqiong Wen
- Chenxi Qin
- Qinyi He
Institutions
- Army Medical University (CN)
- Sichuan University (CN)
- West China Second University Hospital of Sichuan University (CN)
- Stomatological Hospital of Chongqing Medical University (CN)
- Southern Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Cell Reports
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1016/j.celrep.2024.114690
- Citations
- 13
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 3.67